JOSE ANGEL
FONTENLA GIL
Profesor titular de universidade
Publicacións (45) Publicacións de JOSE ANGEL FONTENLA GIL
2024
-
Toxicological assessment of the Achyrocline satureioides aqueous extract in the Caenorhabditis elegans alternative model
Journal of Toxicology and Environmental Health - Part A: Current Issues, Vol. 87, Núm. 18, pp. 730-751
2023
-
8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies
European Journal of Medicinal Chemistry, Vol. 248
2021
-
Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug
European Journal of Pharmacology, Vol. 906
2020
-
Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies
Bioorganic Chemistry, Vol. 101
-
Gamma-decanolactone attenuates acute and chronic seizures in mice: a possible role of adenosine A1 receptors
Behavioural pharmacology, Vol. 31, Núm. 6, pp. 544-552
-
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy
Bioorganic Chemistry, Vol. 104
2018
-
Alkaloids as MAO-A inhibitors: Towards the final solution for depression and anxiety
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 169-192
2017
-
Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases
Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347
-
MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations
MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796
2016
-
Neuropharmacological effects of the ethanolic extract of Sida acuta
Brazilian Journal of Pharmacognosy, Vol. 26, Núm. 2, pp. 209-215
2015
-
Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice
Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1750-1754
2014
-
Comparison of the antidepressive effects of trans-resveratrol and 5-methoxy-7H-dibenzo[de,h]quinolin-7-one.
Current topics in medicinal chemistry, Vol. 14, Núm. 2, pp. 234-238
-
Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases
Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383
2013
-
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
European Journal of Medicinal Chemistry, Vol. 63, pp. 151-161
2008
-
ANXIOLYTIC/HYPNOTIC AND MIORRELAXANT ACTIVITIES OF AZEPINE DERIVATIVES
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
-
HOMOCYSTINE-INDUCED DAMAGE IN DOPAMINERGIC NIGROSTRIATAL PATHWAYS
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
2003
-
New arylpiperazine derivatives with high affinity for α1A, D2 and 5-HT2A receptors
Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 2, pp. 175-178
-
Synthesis of glycosyl derivatives as dopamine prodrugs: Interaction with glucose carrier GLUT-1
Organic and Biomolecular Chemistry, Vol. 1, Núm. 5, pp. 767-771
2000
-
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy- 2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands
Journal of Medicinal Chemistry, Vol. 43, Núm. 4, pp. 599-608
-
Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: Synthesis and determination of affinities at D2, 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors
European Journal of Medicinal Chemistry, Vol. 35, Núm. 1, pp. 83-95